Amphastar Pharmaceuticals (AMPH) Capital Leases (2013 - 2018)

Amphastar Pharmaceuticals' Capital Leases history runs 6 years deep, the most recent figure standing at $1.1 million for Q4 2018.

• In Q4 2018, Capital Leases fell 22.25% year-over-year to $1.1 million; the TTM figure through Dec 2018 stood at $1.1 million (down 22.25% YoY), while the FY2018 annual figure was $1.1 million, down 22.25% from the prior year.
• Capital Leases was $1.1 million for Q4 2018 at Amphastar Pharmaceuticals, down from $1.1 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $1.9 million in Q2 2016 to a low of $802000.0 in Q4 2015.
• Historically, Capital Leases has averaged $1.3 million across 5 years, with a median of $1.2 million in 2018.
• The sharpest annual moves came in 2016 and 2018: Capital Leases surged 101.25% in 2016, then fell 22.25% in 2018.
• A 5-year view of Capital Leases shows it stood at $1.0 million in 2014, then fell by 21.53% to $802000.0 in 2015, then jumped by 101.25% to $1.6 million in 2016, then decreased by 15.92% to $1.4 million in 2017, then dropped by 22.25% to $1.1 million in 2018.
• The last three Capital Leases figures came in at $1.1 million (Q4 2018), $1.1 million (Q3 2018), and $1.2 million (Q2 2018), per Business Quant data.